Browse by author
Lookup NU author(s): Dr Karim Bennaceur, Dr Catherine Drummond, Professor Jane Endicott, Emeritus Professor Bernard Golding, Professor Roger Griffin, Dr Karen Haggerty, Professor Herbie Newell, Professor Martin NobleORCiD, Qing Xu, Dr Yan Zhao, Professor John LunecORCiD, Dr Ian HardcastleORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Structure-activity relationships for the MDM2-p53 inhibitory activity of a series of A-ring substituted 2-N-benzyl-3-(4-chlorophenyl)-3-(1-(hydroxymethyl) cyclopropyl)methoxy) isoindolinones have been investigated, giving rise to compounds with improved potency over their unsubstituted counterparts. Isoindolinone A-ring substitution with a 4-chloro group for the 4-nitrobenzyl, 4-bromobenzyl and 4-cyanobenzyl derivatives (10a-c) and substitution with a 6-tert-butyl group for the 4-nitrobenzyl derivative (10j) were found to confer additional potency. Resolution of the enantiomers of 10a showed that potent MDM2-p53 activity resided in the (-)-enantiomer (-)-10a; IC50 = 44 +/- 6 nM). The cellular activity of key compounds has been examined in cell lines with defined p53 and MDM2 status. Compounds 10a and (-)-10a increase p53 protein levels, activate p53-dependent MDM2 and p21 transcription in MDM2 amplified cells, and show improved selectivity for growth inhibition in wild type p53 cell lines over the parent compound. (C) 2011 Elsevier Ltd. All rights reserved.
Author(s): Watson AF, Liu JF, Bennaceur K, Drummond CJ, Endicott JA, Golding BT, Griffin RJ, Haggerty K, Lu XH, McDonnell JM, Newell DR, Noble MEM, Revill CH, Riedinger C, Xu Q, Zhao Y, Lunec J, Hardcastle IR
Publication type: Article
Publication status: Published
Journal: Bioorganic & Medicinal Chemistry Letters
Year: 2011
Volume: 21
Issue: 19
Pages: 5916-5919
Print publication date: 09/08/2011
ISSN (print): 0960-894X
ISSN (electronic): 1464-3405
Publisher: Pergamon
URL: http://dx.doi.org/10.1016/j.bmcl.2011.07.084
DOI: 10.1016/j.bmcl.2011.07.084
Altmetrics provided by Altmetric
